dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Griguolo, Gaia |
dc.contributor.author | Pascual, Tomás |
dc.contributor.author | Fasani, Roberta |
dc.contributor.author | Chic, N. |
dc.contributor.author | Antunes de Melo Oliveira, Ana Mafalda |
dc.contributor.author | Nuciforo, Paolo Giovanni |
dc.contributor.author | Serna, Garazi |
dc.contributor.author | Guardia, Xavier |
dc.date.accessioned | 2021-11-15T11:51:12Z |
dc.date.available | 2021-11-15T11:51:12Z |
dc.date.issued | 2021-03-19 |
dc.identifier.citation | Griguolo G, Serna G, Pascual T, Fasani R, Guardia X, Chic N, et al. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer. NPJ Precis Oncol. 2021 Mar 19;5(1):23. |
dc.identifier.issn | 2397-768X |
dc.identifier.uri | https://hdl.handle.net/11351/6546 |
dc.description | Mancha de plasma seco; Hepatitis C; Tarjeta de separación de plasma |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | NPJ Precision Oncology;5(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Tractament |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /therapy |
dc.subject.mesh | Neoadjuvant Therapy |
dc.title | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41698-021-00163-6 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /terapia |
dc.subject.decs | tratamiento neoadyuvante |
dc.relation.publishversion | https://doi.org/10.1038/s41698-021-00163-6 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Griguolo G] Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Serna G, Fasani R, Guardia X] Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pascual T] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. [Chic N] Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. [Oliveira M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Breast Cancer and Melanoma Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Nuciforo P] Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain |
dc.identifier.pmid | 33742063 |
dc.identifier.wos | 000631563100004 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00904 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |